Format

Send to

Choose Destination
Hum Reprod. 2017 Jan;32(1):103-111. Epub 2016 Nov 5.

Preconception use of pain-relievers and time-to-pregnancy: a prospective cohort study.

Author information

1
Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, 3rd Floor, Boston, MA 02118, USA kamci@bu.edu.
2
Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, 3rd Floor, Boston, MA 02118, USA.
3
RTI Health Solutions, PO Box 12194, Research Triangle Park, NC 27709, USA.
4
Department of Clinical Epidemiology, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus, Denmark.

Abstract

STUDY QUESTION:

To what extent is preconception use of pain-relieving medication associated with female fecundability?

SUMMARY ANSWER:

Women who used naproxen or opioids had slightly lower fecundability than women who did not use any pain-relieving medications; use of acetaminophen, aspirin and ibuprofen was not appreciably associated with fecundability.

WHAT IS KNOWN ALREADY:

Over-the-counter pain-relieving medications are commonly used by women of reproductive age in the USA. Studies investigating the effects of pain-relieving medication use on ovulation, implantation and fecundability have shown conflicting results.

STUDY DESIGN, SIZE, DURATION:

We analyzed data from an internet-based prospective cohort study of 2573 female pregnancy planners aged 21-45 years from the USA and Canada. Participants were enrolled and followed from June 2013 through September 2015. Participants completed a baseline questionnaire and bimonthly follow-up questionnaires until a reported pregnancy or for 12 months, whichever occurred first. Over 80% of participants completed at least one follow-up questionnaire.

PARTICIPANTS/MATERIALS, SETTING, METHODS:

Use of pain-relieving medication during the past month was assessed at baseline and on each follow-up questionnaire. Medications were categorized according to type (acetaminophen, aspirin, ibuprofen, naproxen and opioids) and total monthly dose. Self-reported pregnancy was assessed at each follow-up. Multivariable-adjusted fecundability ratios (FRs) and 95% CI were calculated using proportional probabilities regression. Models were adjusted for demographic, lifestyle and anthropometric factors; reproductive history; gynecologic morbidity; and indications for use of pain medications. Models were also run with and without adjustment for parity. After restricting to women with 6 or fewer months of attempt time at study entry, 1763 were included in the analyses.

MAIN RESULTS AND THE ROLE OF CHANCE:

At baseline, 1279 (73%) women reported using ≥1 pain-relieving medications in the previous month. When compared with non-use of pain-relieving medications, FRs for use of naproxen and opioids at baseline were 0.78 (95% CI: 0.64-0.97) and 0.81 (95% CI: 0.60-1.10), respectively. A dose-response relation was observed between naproxen use and fecundability; FRs for use of <1500 and ≥1500 mg of naproxen were 0.85 (95% CI: 0.68-1.07) and 0.58 (95% CI: 0.36-0.94), respectively. Small numbers (n = 74) precluded the examination of opioid use by dose. Overall, there was little evidence of an association between fecundability and acetaminophen (FR 1.04, 95% CI: 0.92-1.18), aspirin (FR 1.00, 95% CI: 0.80-1.25), or ibuprofen (FR 1.00, 95% CI: 0.89-1.11). Similar results were observed when exposure information was updated over time.

LIMITATIONS, REASONS FOR CAUTION:

Numbers of opioid users were small. Information collected on reason for use of pain medications was not specific to each type of pain medication. Therefore, we cannot rule out confounding by indication as an explanation of these results.

WIDER IMPLICATIONS OF THE FINDINGS:

Use of naproxen and opioids was associated with a small reduction in fecundability, but there was little association between other pain-relieving medications and fecundability.

STUDY FUNDING/COMPETING INTERESTS:

This study was supported through funds provided by National Institute of Child Health and Human Development, National Institute of Health (R21 HD072326, T32 HD052458). The authors have no conflicts of interest to disclose.

TRIAL REGISTRATION NUMBER:

Not applicable.

KEYWORDS:

acetaminophen; conception; fecundability; fertility; non-steroidal anti-inflammatory drugs; opioids; pain medications; time-to-pregnancy

PMID:
27816920
PMCID:
PMC5165076
DOI:
10.1093/humrep/dew272
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center